Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of High Intra-abdominal Pressure on Cisplatin Diffusion During HIPEC
2013-005282-39Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in peritoneal carcinomatosis (PC), colorectal cancer (CRC) and pseudomyxoma peritonei (PMP), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoints: cisplatin concentration in residual neoplastic tissue and cisplatin pharmacokinetics. Started Jan 2014; status: completed.
02
Drugs
cisplatin
03
Conditions
peritoneal carcinomatosis (PC)colorectal cancer (CRC)pseudomyxoma peritonei (PMP)
Beyond the preview
Go deeper on 2013-005282-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005282-39.